The Atlantic
What Americans Don’t Know About Their Medications
People who have faced debilitating side effects say we need better warnings on drugs. The FDA hasn’t been enthusiastic.
The Atlantic
A few days ago, an unusual offer landed in my inbox. “Do you want to interview this man before he ends his life?” read the subject line of the message sent by Linda Martin, who, out of concerns for her safety, would tell me only that she is in her 60s and lives on the West Coast.
She said that John Fratti, a 50-year-old former pharmaceutical-sales representative, was “making plans to end his life in the next few weeks because he can no longer stand the pain caused by Fluoroquinolone Toxicity.” That’s the term Martin and others use to describe the side effects of fluoroquinolone antibiotics, a class of drugs that includes ciprofloxacin, sometimes called Cipro, and levofloxacin, or Levaquin, which are taken for severe bacterial infections. She added that Fratti had already o
What Americans Don t Know About Their Medications msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
POLITICO
Get the Future Pulse newsletter
Email
Sign Up
By signing up you agree to receive email newsletters or updates from POLITICO and you agree to our privacy policy and terms of service. You can unsubscribe at any time and you can contact us here. This sign-up form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Technical difficulties delayed the delivery of Future Pulse this morning. We apologize for the inconvenience.
The Big Idea
When Covid-19 started sweeping the United States a year ago, many radiology practices
shut down almost immediately. Much of their work from mammograms to lung cancer screening wasn’t deemed a priority as the mysterious new virus spread. And telemedicine wasn’t an option; radiologic imaging must be done in person.
Routine cancer screening tests have crashed due to COVID-19 chicagotribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chicagotribune.com Daily Mail and Mail on Sunday newspapers.
In dire need of a refocused research agenda
23 Dec 2020 A doctor collects a swab sample from a man to be tested for the coronavirus disease (COVID-19) outside Clinic Ajwa in Shah Alam, Malaysia. File/Reuters
Steven Woloshin, Paul Glasziou and Susan Michie,
Tribune News Service
The COVID-19 pandemic has seen remarkable and rapid research in vaccines and therapeutics, but disappointingly little research to shed light on the interventions we currently use to reduce SARS-CoV2 transmission. That is a problem because even with vaccines on the way, we will be stuck with COVID-19 for a considerable time. We urgently need more research to identify and disseminate the most effective and least disruptive interventions and practices to reduce virus transmission, for this pandemic and the ones that will inevitably follow.